We describe an isocratic liquid-chromatographic method with amperometric detection for determination of serotonm by rapid sample preparation. Serotonin, a central neurotransmitter, has been associated with several psychiatric disorders. In addition, serotonin is one of the vasoactive substances secreted by carcinoid tumors, and is responsible for the carcinoid syndrome, characterized by flushing, diarrhea, and valvular lesions of the heart. Determination of the urinary excretion of 5-hydroxyindoleacetic acid (5-HIAA), the major metabolite of serotonin, has been the principal laboratory test for the diagnosis of serotonin overproduction by carcinoid tumors. Additional measurements of urinary, plasma, and platelet serotonin reportedly increased the sensitivity of the diagnosis of serotonin overproduction
GIuDIcELLI
We describe an isocratic liquid-chromatographic method with amperometric detection for determination of serotonm by rapid sample preparation. Serotonin, a central neurotransmitter, has been associated with several psychiatric disorders. In addition, serotonin is one of the vasoactive substances secreted by carcinoid tumors, and is responsible for the carcinoid syndrome, characterized by flushing, diarrhea, and valvular lesions of the heart. Determination of the urinary excretion of 5-hydroxyindoleacetic acid (5-HIAA), the major metabolite of serotonin, has been the principal laboratory test for the diagnosis of serotonin overproduction by carcinoid tumors. Additional measurements of urinary, plasma, and platelet serotonin reportedly increased the sensitivity of the diagnosis of serotonin overproduction [1] .
Platelet
Because most blood serotonin is stored in the platelets and because the release reaction of serotonin occurs easily, platelet and plasma measurements are complicated by artifacts caused by sample conservation and (or) preparation. Thus, many investigators tend to prefer whole-blood assay.
In tissues and body fluids, radioenzymatic assay [2] [3] [4] [5] , RIA [6] [7] [8] [9] , enzyme immunoassay [10] , and fluoromet.ric methods for determining serotonin [11, 12] exhibit a lack of sensitivity or specificity or are time consuming. Various liquid-chromatographic methods that incorporate electrochemical [13] [14] [15] [16] [17] [18] and fluorometric [19] [20] [21] [22] [23] detection can determine serotonin concentrations in platelet-rich plasma and in serum after a single deproteinization step. In whole blood, the presence of the hemoglobin iron and of oxygen alters the recovery of serotonin during deproteinization with concentrated perchloric acid. Ascorbic acid can be added before deproteinization when fluorometric detection is used [19, 20, 24] . However, ascorbic acid interferes with amperometric detection of serotonin. Conversion of free oxyhemoglobin to carboxyhemoglobin by bubbling carbon monoxide through the blood sample before precipitating proteins prevents serotonin oxidation [25] .
Serotonin has been measured in urine by radioenzymatic assay [26] and liquid chromatography with fluorometric [27] or electrochemical [28] detection. These methods have been combined into a cation-exchange purification step to increase selectivity. However, the serotonin peak was not always completely separated from interfering compounds. Direct injection of diluted and filtered urine samples was developed to profile serotonin and related indols by HPLC with fluorometric detection [23] . Nevertheless, the quaternary gradient elution required was time consuming and too complicated for daily routine use.
We report here a sensitive and specific liquid-chromatographic assay with amperometric detection to determine serotonin concentrations after a rapid preparation step in various biological samples, plasma, whole blood, platelets, and urine. 143-1255), respectively, were obtained from Bio-Rad Labs.
(Richmond, CA). All other chemicals were of analytical grade.
SUBJECTS
Normal serotonin concentrations were determined in eight healthy subjects, ages 27-39 years (mean 33 years), who had not taken serotonin-containing food during the 48-h period preceding urinary and blood sampling. Ten patients with biopsyproven carcinoid tumors were ages 29-68 years (mean 54 years). The carcinoid tumors were of midgut (ileum, n = 7) or foregut (bronchus, n = 2; stomach, n = 1; pancreas, n = 1) origin. In both healthy subjects and patients with carcinoid tumors, serotonin concentrations were determined in whole blood, plateletpoor plasma, isolated platelets, and urine.
The influence of platelet count on whole-blood serotonin concentrations was determined on blood samples from 15 hypertensive patients ages 41-63 years (mean 52 years) after 1 h in a supine position and after 1 h of moderate exercise. Platelet, whole-blood, and platelet-poor plasma serotonin concentrations were determined.
SAMPLE COLLECTION
Venous blood (10 mL) was withdrawn into glass Vacutainer Tubes containing disodium EDTA (Becton Dickinson, Paris, France). After platelets were counted with a Model S plus 4
Coulter Counter (Coulter Electronics, Paris, France), the tubes were gently inverted and a l-mL aliquot was collected for whole-blood serotonin determination. The remaining whole blood was centrifuged at room temperature for 15 mm at 200g to obtain a platelet-rich plasma. After platelets were counted in platelet-rich plasma, 300 ML of platelet-rich plasma was separated into platelet-poor plasma and a pellet by centrifugation at room temperature for 30 mm at 1000g.
Twenty-four-hour urines of subjects were collected in 2-L brown polypropylene bottles and acidified to pH 4 with acetic acid.
Whole blood, platelet-poor plasma, urine, and isolated platelets were stored at -20 #{176}C and analyzed within 1 week after collection.
SAMPLE PREPARATION
To 250 ML of whole blood and platelet-poor plasma we added successively 25 ML (650 and 50 pmol, respectively) of internal standard solutions of N-methylserotonin (26 and 2 Mm0IIL, respectively) and 50 ML of 100 g/L sodium borohydride. After mixing, 50 ML of 20% perchloric acid were added. After vortex-mixing, the tubes were centrifuged at 1000g and 4 #{176}C for 20 mm, and 40 ML of the resulting supernate was injected into the chromatograph. Frozen platelet pellets were thawed at room temperature. Distilled water (300 ML) and an internal standard solution of N-methylserotonin (75 ML; 400 pmol) were added to each tube. After addition of 50 ML of 20% perchloric acid solution, the tubes were vortex-mixed and centrifuged, and 40 ML of supernate was injected into the chromatograph.
To 2 mL of urine were added 25 ML of an internal standard solution of N-methylserotomn (1300 pmol) and 5 mL of 0.05 mollL ammonium pentaborate containing 1 g/L EDTA. The pH was adjusted to 6 with HCI (2 mol/L). The mixture was applied to the cation-exchange column equilibrated in ammonium acetate (0.03 mol/L, pH 6.5). The column was washed with 10 mL of distilled water and eluted with 8 mL of 2 mol/L ammonium hydroxide. The eluate was applied to the anionexchange column equilibrated in a solution of sodium acetate (0.01 mol/L, pH 4.5). The column was washed with 10 mL of distilled water and eluted with 5 mL of 0.2 moVL ammonium acetate adjusted to pH 6 with acetic acid (1 mol/L). The eluate (50 ML) was injected into the chromatograph.
For 5-HJAA measurements, 200 ML of urine was mixed with 800 ML of an internal standard (5-hydroxyindole-2-carboxylic acid, 2.5 mmol/L in ethanol). After centriftigation for 5 mm at 1000g, 200 ML of supernate was added to 800 ML of water and 25 ML was injected into the chromatograph.
Urinary creatinine concentrations were measured by a picric acid method on an SMA-2 analyzer (Technicon Instruments, Paris, France).
CALIBRATION

Calibration
curves were generated by supplementing blank platelet-poor plasma, whole blood, or urine with stock serotonin solutions to yield final concentrations of 6, 28, 57, 142, and 284 nmol/L for platelet-poor plasma; 142, 284, 567, 1135, 2270, 3405, and 4540 nmol/L for whole blood; and 284, 567, 1419, 2837, and 5675 nmol/L for urine. Platelet serotonin measurements were calibrated with aqueous serotonin solutions of 142, 284, 567, and 1135 nmolIL. The reproducibility of the method was evaluated from multiple analysis of supplemented samples containing 28,1135, and 1418 nmol/L serotonin for plateletpoor plasma, whole blood, and urine, respectively, and of an aliquot of a platelet pooi. The recoveries of serotonin and internal standard were determined by the analysis of platelet- poor plasma, urine, and platelet pool without and with enrichment of serotonin.
In whole blood, recoveries were assessed by a similar procedure at four different serotonin concentrations with increasing concentrations of sodium borohydride. Detection limits were determined by injecting extracts of platelet-poor plasma, urine, platelet pooi, or whole blood that were previously supplemented with decreasing concentrations of serotonin. Detection limit was defined as the lowest injected amount that produced a signal-to-noise ratio of 3. Calibration 
mm
Results
Representative chromatograms of samples of platelet-poor plasma, whole blood, platelets, and urine are illustrated in Fig. 1 The within-day precisions, expressed as the CV (mean ± SD) evaluated from multiple analysis (n = 10) of supplemented same-day samples, were 8% (26 ± 2), 7% (1145 ± 78), 4%
(4243 ± 180), and 5% (1406 ± 76) for platelet-poor plasma, whole blood, platelets, and urine, respectively. The day-to-day precisions, obtained by analysis for 10-day samples prepared on the same day and stored at -20 #{176}C, were 9% (28 ± 3), 6% (1141 ± 72), 7% (4255 ± 284), and 4% (1417 ± 52) for platelet-poor plasma, whole blood, platelets, and urine, respectively.
The recoveries (%, mean ± SD) were calculated by comparing the measured values of supplemented samples of each medium with those of aqueous calibration solutions for five analyses. The recoveries of serotonin were 93.0% ± 2.0% at 57 nmol/L and 98.2% ± 4.1% at 284 nmol/L for platelet-poor plasma and platelet pellets, respectively. In urine, the recovery of serotonin was 78.2% ± 3.6% at a concentration of 567 nmol/L. As shown in Table 1 , the recovery of serotonin in whole blood increased dose-dependently with the concentration of the antioxidant added before deproteinization.
For each sodium borohydride concentration, the recovery of serotonin in supplemented whole-blood samples was similar for all concentrations of serotonin added. The recovery of serotonin in whole blood also was not different with sodium borohydride concentrations of 100 and 150 g/L. Similarly, the recovery of the internal standard was 72.5% ± 4.2% for a concentration of 100 g/L sodium borohydride. No interference was observed with sodium borohydride on the chromatographic separation. When urine samples were supplemented with increasing 5-HIAA concentrations, calibration curves were linear from 5 to 500 Mm0IIL. The recoveries of 5-HIAA were 95% ± 4% and 97% ± 4% for concentrations of 25 and 100 MmolfL, respectively. For 5-HIAA concentrations of 25 and 100 Mmol/L, the within-run CVs (mean ± SD) were 4.5% (25 ± 1 MmOl/L) and 4.5% (100.4 ± 4.5 MmolfL), respectively, and day-to-day CVs nmol/L were determined in isolated platelets and platelet-poor plasma, respectively. In whole blood, serotonin concentrations were 1515 ± 845 nmol/L and, when corrected for platelet number, 3507 ± 1322 pmolJlO9 platelets. Serotonin concentrations in isolated platelets correlated better with whole-blood concentrations expressed as pmol/109 platelets (y = 0.97x + 17.9, r = 0.969) than expressed as nmolfL (y = 0.466x -22.4, r = 0.72 7). In urine, serotonin excretion was 817 ± 193 nmol/24 h and 52 ± 13 nmol/mmol of creatinine, and excretion 5-HIAA was 28 ± 7 Mmol/24 h and 1862 ± 513 Mmol/mmol of creatinine.
In hypertensive patients, platelet-poor plasma serotonin concentrations were similar in supine (14.2 ± 5.7 nmol/L) and standing positions (12.1 ± 3.8 nmollL). Whole-blood serotonin concentrations were significantly higher while standing (1209 ± 1010 nmol/L) than while supine (999 ± 749 nmol/L, P <0.001).
In contrast, platelet serotonin concentrations were similar in both positions (2372 ± 1050 and 2378 ± 1055 pmolJlO9 platelets, respectively).
In these patients, platelet counts increased substantially from supine position (397 X 10' ± 132 x 10' platelets/L) to standing position (466 X 10' ± 131 )< 10' platelets/L, P <0.05). When whole-blood serotonin concentrations were corrected for platelet number, whole-blood values were similar in supine and standing positions (2446 ± 1254 and 2480 ± 1560 pmolJlO' platelets, respectively). Table 2 illustrates the serotonin and 5-HIAA values obtained from patients with carcinoid tumors. A highly significant correlation was observed between whole-blood serotonin concentrations corrected for platelet numbers and isolated platelet concentrations (y = 0.885x + 146, r = 0.9977, P <0.001), and all patients had both concentrations above the normal range. In contrast, two thrombocytopenic patients (subjects 7 and 10) had normal whole-blood serotonin concentrations, expressed in nmol/L, leading to false-negative determinations.
Patients with normal or minimally increased urinary excretion of 5-HIAA had increased serotonin concentrations in blood and (or) in urine.
Patients with midgut carcinoid tumors also had serotonin concentrations above normal in platelet-poor plasma. In contrast, patients with foregut carcinoid tumors had lower plateletpoor plasma serotonin concentrations associated with urine and (or) whole-blood concentrations above the normal range.
Discussion
We report a sensitive and reproducible isocratic HPLC method with amperometric detection for the determination of serotonin in various biological fluids. The chromatographic conditions of the method are suitable for analysis of serotonin in platelet-poor plasma, platelets, whole blood, and urine.
Platelet-poor plasma and platelet samples were prepared with a single deproteinization step, and normal values agreed with those of previous studies [10, 13-15, 18, 19, 22, 26] . In wholeblood samples, deproteinization with perchloric acid leads to oxidation of serotonin and a low recovery with amperometric detection. Addition of ascorbic acid as antioxidant to wholeblood samples before deproteinization broadens the solvent front so much that it interferes with the serotonin peak. Bubbling carbon monoxide through the blood samples before precipitating proteins converts oxyhemoglobmn to carboxyhemoglobmn and inhibits the destruction of serotonin by free oxyhemoglobin, but is not easily effected in clinical chemistry [25] . In contrast, adding an antioxidant solution of sodium borohydride to whole blood before the deproteinization step prevents the loss of serotonin in the samples without analytically interfering with the amperometric detection. This direct measurement of serotonin in whole blood yielded a reference range of values (nmol/L) of whole blood that agreed with data previously described after fluorometric [19] and amperometric detection [24] . In standing hypertensive patients, however, a discrepancy between whole-blood and platelet serotonin concentrations was observed. The lack of positional effects on serotonin concentrations in platelet-poor plasma suggested that this discrepancy Pussard et al.: HPLC-amperometric detection of serotonin could be due to the increase in platelet counts induced by moderate exercise. Hence, accurate whole-blood serotonin determinations must be corrected for platelet count to eliminate possible variations of circulating platelets. By comparison of whole blood and platelets concentrations, >95% of wholeblood serotonin is located in platelets, and whole-blood serotonm concentrations in pmolf 10' platelets were highly correlated with isolated platelet concentrations in both healthy subjects and patients with carcinoid tumors. Although serotonin concentrations in platelet-rich plasma can be measured with this method, estimation of whole-blood serotonin corrected for platelet number must be preferred to avoid time-consuming isolation of platelets. This method also allows the sample preparation to be delayed.
In urine, serotonin excretion was previously evaluated by HPLC methods with fluorometric [21, 23] or amperometric detection [28] and by enzyme immunoassay [10] . In these methods, sample preparation required extraction on a cationexchange column, which did not allow complete separation of serotonin or of internal standard from interfering compounds. Direct injection of diluted urine samples required a timeconsuming quaternary elution gradient that is not adapted to routine use [23] . The use of two successive anion-and cationexchange columns for sample clean-up affords an improved selectivity in clinical routine without decreasing the serotonin recovery. Normal values expressed in nmol/24 h or in nmoll mmol of creatinine and obtained with our method agreed with those previously described [10, 21, 23, 28] . Our chromatographic conditions also allowed us to separate and to quantify 5-HIAA in urine.
Several arguments favor a simultaneous determination of serotonin in both urine and whole blood in conjunction with urinary 5-HIAA excretion. First, whereas ingestion of serotonm-rich foods such as bananas, pineapples, or walnuts increases urinary 5-HIAA excretion, leading to false-positive results, platelet or urinary free serotonin is not influenced by short-term ingestion of these serotonin-rich foods [20, 29] . Second, because of the biochemical diversity of carcinoid tumors, measurements of serotonin in whole blood and urine can give additional information for diagnosis. Foregut tumors are deficient in aromatic amino acid decarboxylase and secrete 5-hydroxytryptophan rather than serotonin. Hence, patients with these tumors have usually normal serotonin concentrations in blood and in platelets. Some of this 5-hydroxytryptophan is decarboxylated to serotonin by the kidney, and urinary excretion of both unchanged 5-hydroxytryptophan and serotonin is increased. Good correlation has been demonstrated between 5-hydroxytryptophan and serotonin excretions in urine [26] . In addition, some patients with carcinoid tumors of midgut origin have minimally increased or normal values for 5-HIAA excretion [1] . In these patients, measurements of whole-blood or platelet and urinary serotonin give more relevant information for the diagnosis of those carcinoid tumors that secrete small amounts of serotonin than does the urinary 5-HIAA excretion value.
In conclusion, this HPLC with amperometric detection method coupled with rapid sample preparations allows exploration of serotonin metabolism in various biological fluids and laboratory evaluation of patients with suspected carcinoid tumors. This evaluation should not be limited to urinary excretion of 5-I-IIAA but should also include the determination of serotonin in urine and in whole blood or platelets because these are the most and consistently increased markers during long-term monitoring of patients with carcinoid tumors, especially those of fore-and midgut origins.
